newsfilter
← Latest News
GlobeNewswire·

AccuStem Sciences to Offer its MSC Blood Test to Lung Cancer Screening Programs in the United States

LONDON and PHOENIX, April 04, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB:ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, announces plans